Please login to the form below

Not currently logged in
Email:
Password:

Mexico

This page shows the latest Mexico news and features for those working in and with pharma, biotech and healthcare.

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

As part of that agreement, Novartis gained development and commercialisation rights to tislelizumab in the US, Canada, Mexico, the EU, UK, Norway, Switzerland, Iceland, Liechtenstein, Russia and Japan for an upfront

Latest news

More from news
Approximately 3 fully matching, plus 145 partially matching documents found.

Latest Intelligence

  • If you’re going global, go local and go early If you’re going global, go local and go early

    Virgo’s London team recently worked with colleagues from Istanbul, Beijing, Bangalore, Delhi, Guangzhou, Mexico City, Mumbai, Shanghai and São Paulo to create a three-year, global campaign to challenge consumers

  • Deal Watch February 2017 Deal Watch February 2017

    Under the original licence Vifor's rights covered Europe, Canada, Mexico, Central and South America and South Korea.

  • Deal Watch June 2016 Deal Watch June 2016

    countries including Mexico, the Dominican Republic and Cuba. ... Excludes US. US. † Excludes China, Korea. †† 28 EU member states, Switzerland, Iceland, Norway, Lichtenstein, all LatAm countries including  Mexico, Dominican Republic and Cuba. ‡

  • Having it all: Women in wealthy countries consider what makes them happy Having it all: Women in wealthy countries consider what makes them happy

    Indeed, the main factor in promoting well-being is health, not wealth, according to the EIU survey of 453 women in five countries (Germany, France, Brazil, Mexico and India).

  • Deal Watch May 2016 Deal Watch May 2016

    Vifor has secured a wide range of territories in the deal, including Europe, Canada, Mexico, Australia and South Korea plus an option to US marketing rights for the treatment of dialysis ... 293. OPKO Health/ Vifor Fresenius. Licence. Rayaldee in EP, CA,

More from intelligence
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics